1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 16,950 | 17,300 | 18:33 | |
| 16,940 | 17,288 | 18:34 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| MINIMED GROUP Aktie jetzt für 0€ handeln | |||||
| Fr | MiniMed Flex now integrated with Abbot's Instinct sensor | 1 | MassDevice | ||
| Fr | Can Abbott Laboratories (ABT)'s Instinct Sensor Give MiniMed Group (MMED) a Competitive Edge? | 8 | Insider Monkey | ||
| 17.08. | MiniMed Flex insulin pump now ships with Abbott's Instinct sensor | 3 | Investing.com | ||
| 10.08. | BofA raises MiniMed Group stock price target to $24 on exchange timing | 2 | Investing.com | ||
| 10.08. | BofA hebt Kursziel für MiniMed Group wegen Aktientausch-Timing auf 24 $ an | 5 | Investing.com Deutsch | ||
| 22.07. | MiniMed says Flex insulin pump is now available through Medicare | 2 | MassDevice | ||
| 08.07. | Benchmark reiterates MiniMed Group stock rating on model update | 2 | Investing.com | ||
| 29.06. | MiniMed Group, Inc. - 10-K, Annual Report | 3 | SEC Filings | ||
| 29.06. | MiniMed adds Alcon CEO, Medtronic exec to board of directors | 9 | MassDevice | ||
| 29.06. | MiniMed Group, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 29.06. | MiniMed appoints Alcon CEO David Endicott and Linnea Burman to its Board of Directors | 795 | PR Newswire | David Endicott, Chief Executive Officer of Alcon, brings global healthcare leadership and public company experience; Linnea Burman adds MedTech operating depth NORTHRIDGE, Calif., June... ► Artikel lesen | |
| 24.06. | MiniMed Launches Abbott's Instinct Sensors Across European Markets | 9 | Zacks | ||
| 23.06. | MiniMed launches Instinct sensors made by Abbott with insulin delivery tech in Europe | 13 | MassDevice | ||
| 23.06. | MiniMed launches Instinct sensors in Europe giving people with diabetes more sensor choice with the same proven outcomes | 1.087 | PR Newswire | MiniMed automated insulin delivery and smart MDI systems can now be paired with Instinct and Instinct Go, made by Abbott, the smallest, longest-wear sensors in the company's portfolioNORTHRIDGE... ► Artikel lesen | |
| 17.06. | MiniMed begins miniature Flex pump rollout in US | 2 | MassDevice | ||
| 12.06. | Benchmark reiterates MiniMed Group stock rating on product launches | 1 | Investing.com | ||
| 04.06. | Benchmark reiterates Buy on MiniMed stock, cites product launches | 2 | Investing.com | ||
| 04.06. | Piper Sandler bestätigt "Neutral"-Rating für MiniMed mit Kursziel von 16 $ | 1 | Investing.com Deutsch | ||
| 04.06. | Piper Sandler reiterates Neutral rating on MiniMed stock at $16 | 1 | Investing.com | ||
| 03.06. | MiniMed Group Shares Surge 14% Over Strong Revenue Growth In Q4 | 1 | RTTNews |
1 2 3 4 5 Weiter >>
89 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 40,390 | +0,47 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| HEALWELL AI | 0,470 | -4,38 % | HEALWELL AI: HEALWELL AI's DARWEN AI Platform Nominated for 2026 International Prix Galien, the Global "Best of the Best" in Life Sciences Innovation | Pentavere advances from winning the 2024 Prix Galien USA Award to competing internationally among Prix Galien winners from around the world, further validating DARWEN AI as a globally recognized... ► Artikel lesen | |
| LIFEWARD | 7,240 | -1,09 % | H.C. Wainwright reiterates Lifeward stock rating on revenue growth | ||
| IMUNON | 1,430 | +2,88 % | Imunon, Inc.: IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer | Enrollment momentum exceeding expectations is based on highly promising survival (OS) data and well tolerated safety profile demonstrated in the Company's large, randomized Phase II study, OVATION... ► Artikel lesen | |
| INSPIREMD | 0,725 | -0,68 % | InspireMD Targets $9 Million Of Annual Cost Savings As CGuard TCAR Study Reports 100% Acute Device Success | ||
| MYOMO | 1,488 | +0,13 % | Myomo expects $45M-$47M full-year revenue while targeting second-half cash burn below $2M | ||
| GT BIOPHARMA | 0,299 | +3,50 % | GT Biopharma, Inc.: GT Biopharma Reports Second Quarter 2026 Financial Results | Phase 1 trial evaluating GTB-3650 TriKE- remains ongoing, with an update anticipated in 2H 2026 Phase 1 basket trial evaluating GTB-5550 TriKE- in multiple solid tumor types known to express B7-H3... ► Artikel lesen | |
| INOGEN | 4,860 | +0,83 % | Inogen (INGN) Cuts Guidance Even As Profitability Climbs | ||
| MEDLINE | 29,800 | +2,76 % | Medline Inc.: Medline Reports Second Quarter and First Six Months 2026 Results | Second quarter net sales of $7.7 billion, an increase of 11.6%Second quarter net income of $139 million, a decrease of 58.3%Second quarter Adjusted EBITDA1 of $1.1 billion, an increase of 13.4%First... ► Artikel lesen | |
| INTELLIGENT BIO SOLUTIONS | 2,290 | -8,76 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth | Reader installed base grew 22% year-over-year, driving a 35% increase in total consumable cartridges to over 100,000 units Full year gross profit margin expanded to 48.63%, up 778 basis points year-over-year... ► Artikel lesen | |
| GLUCOTRACK | 0,335 | -3,54 % | Glucotrack, Inc. - 8-K, Current Report | ||
| LENSAR | 8,840 | +1,73 % | LENSAR, Inc.: LENSAR Reports First Quarter 2026 Results and Provides Business Update | 7 ALLY Robotic Cataract Laser Systems® ("ALLY System") Placements in First Quarter 2026; Backlog of 11 ALLY Systems as of March 31, 2026 First Quarter Recurring Revenue was $12.6 million Total Laser... ► Artikel lesen | |
| OMADA HEALTH | 20,200 | -1,94 % | Omada Health, Inc.: Omada Health Joins Lilly Employer Connect, Expanding Its Access Pathways for GLP-1 Care as Patients Seek More Lifestyle Support | SAN FRANCISCO, May 07, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA) announced it will serve as an independent program administrator in Eli Lilly and Company's Employer Connect program. Omada... ► Artikel lesen | |
| LEXARIA BIOSCIENCE | 10,420 | -4,54 % | Lexaria Bioscience Corp.: DehydraTECH-enhanced Amycretin and Retatrutide Yield Significant Absorption Improvements in Lexaria's 2026 Animal Study #2 | Proprietary DehydraTECH 3.0 amycretin tablet formulation more than doubled absolute bioavailability compared to a leading industry studyProprietary DehydraTECH 3.0 retatrutide tablet formulation increased... ► Artikel lesen | |
| INCANNEX HEALTHCARE | 3,620 | +1,40 % | Incannex Healthcare: Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea | First clinical sites approved and actively screening potential participantsRepresents another major milestone in the advancement of IHL-42X towards Phase III developmentIHL-42X has received FDA Fast... ► Artikel lesen |
MINIMED GROUP INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -1,47 % bei einem Aktienkurs von 17,258 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MINIMED GROUP INC finden Sie auf Wallstreet Online.